Cargando…

Impact of Anti-Tumor Necrosis Factor and Thiopurine Medications on the Development of COVID-19 in Patients With Inflammatory Bowel Disease: A Nationwide Veterans Administration Cohort Study

Detalles Bibliográficos
Autores principales: Khan, Nabeel, Patel, Dhruvan, Xie, Dawei, Lewis, James, Trivedi, Chinmay, Yang, Yu-Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the AGA Institute 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7258834/
https://www.ncbi.nlm.nih.gov/pubmed/32479823
http://dx.doi.org/10.1053/j.gastro.2020.05.065
_version_ 1783540113580490752
author Khan, Nabeel
Patel, Dhruvan
Xie, Dawei
Lewis, James
Trivedi, Chinmay
Yang, Yu-Xiao
author_facet Khan, Nabeel
Patel, Dhruvan
Xie, Dawei
Lewis, James
Trivedi, Chinmay
Yang, Yu-Xiao
author_sort Khan, Nabeel
collection PubMed
description
format Online
Article
Text
id pubmed-7258834
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher by the AGA Institute
record_format MEDLINE/PubMed
spelling pubmed-72588342020-05-29 Impact of Anti-Tumor Necrosis Factor and Thiopurine Medications on the Development of COVID-19 in Patients With Inflammatory Bowel Disease: A Nationwide Veterans Administration Cohort Study Khan, Nabeel Patel, Dhruvan Xie, Dawei Lewis, James Trivedi, Chinmay Yang, Yu-Xiao Gastroenterology Brief Communication by the AGA Institute 2020-10 2020-05-29 /pmc/articles/PMC7258834/ /pubmed/32479823 http://dx.doi.org/10.1053/j.gastro.2020.05.065 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Brief Communication
Khan, Nabeel
Patel, Dhruvan
Xie, Dawei
Lewis, James
Trivedi, Chinmay
Yang, Yu-Xiao
Impact of Anti-Tumor Necrosis Factor and Thiopurine Medications on the Development of COVID-19 in Patients With Inflammatory Bowel Disease: A Nationwide Veterans Administration Cohort Study
title Impact of Anti-Tumor Necrosis Factor and Thiopurine Medications on the Development of COVID-19 in Patients With Inflammatory Bowel Disease: A Nationwide Veterans Administration Cohort Study
title_full Impact of Anti-Tumor Necrosis Factor and Thiopurine Medications on the Development of COVID-19 in Patients With Inflammatory Bowel Disease: A Nationwide Veterans Administration Cohort Study
title_fullStr Impact of Anti-Tumor Necrosis Factor and Thiopurine Medications on the Development of COVID-19 in Patients With Inflammatory Bowel Disease: A Nationwide Veterans Administration Cohort Study
title_full_unstemmed Impact of Anti-Tumor Necrosis Factor and Thiopurine Medications on the Development of COVID-19 in Patients With Inflammatory Bowel Disease: A Nationwide Veterans Administration Cohort Study
title_short Impact of Anti-Tumor Necrosis Factor and Thiopurine Medications on the Development of COVID-19 in Patients With Inflammatory Bowel Disease: A Nationwide Veterans Administration Cohort Study
title_sort impact of anti-tumor necrosis factor and thiopurine medications on the development of covid-19 in patients with inflammatory bowel disease: a nationwide veterans administration cohort study
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7258834/
https://www.ncbi.nlm.nih.gov/pubmed/32479823
http://dx.doi.org/10.1053/j.gastro.2020.05.065
work_keys_str_mv AT khannabeel impactofantitumornecrosisfactorandthiopurinemedicationsonthedevelopmentofcovid19inpatientswithinflammatoryboweldiseaseanationwideveteransadministrationcohortstudy
AT pateldhruvan impactofantitumornecrosisfactorandthiopurinemedicationsonthedevelopmentofcovid19inpatientswithinflammatoryboweldiseaseanationwideveteransadministrationcohortstudy
AT xiedawei impactofantitumornecrosisfactorandthiopurinemedicationsonthedevelopmentofcovid19inpatientswithinflammatoryboweldiseaseanationwideveteransadministrationcohortstudy
AT lewisjames impactofantitumornecrosisfactorandthiopurinemedicationsonthedevelopmentofcovid19inpatientswithinflammatoryboweldiseaseanationwideveteransadministrationcohortstudy
AT trivedichinmay impactofantitumornecrosisfactorandthiopurinemedicationsonthedevelopmentofcovid19inpatientswithinflammatoryboweldiseaseanationwideveteransadministrationcohortstudy
AT yangyuxiao impactofantitumornecrosisfactorandthiopurinemedicationsonthedevelopmentofcovid19inpatientswithinflammatoryboweldiseaseanationwideveteransadministrationcohortstudy